Apple Eases On Bonus & Hiring, Federal Reserve Mulls Tougher Rules After SVB Failure, Meta-Backed Undersea Cable Project Delayed By China: Today’s Top Stories
Reuters
Fed Mulling Tougher Rules For Midsize Banks After SVB Crash
Prosecutors, SEC Investigate Signature Bank’s Work With Crypto Clients
Justice Department investigators in Washington and Manhattan were investigating Signature Bank's (NASDAQ: SBNY) work with crypto clients before regulators seized the bank past weekend.
Data For Pfizer’s COVID-19 Drug Shows No Possible Association With Infection Rebound
The FDA dropped in briefing document as the agency’s external advisors meet on Thursday (March 16) to discuss complete approval…
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ:AMGN) concealed the dispute over…
Justice Department, SEC Launch Probes Assessing What Went Wrong For Silicon Valley Bank
The Justice Department and the Securities & Exchange Commission have launched a preliminary stage but separate investigation probes looking into the collapse of Silicon Valley Bank (NASDAQ: SIVB)
Ken Griffing Backed Citadel Advisors Discloses 5.3% Stake in Western Alliance Bank
Billionaire Kenneth (Ken) Griffing controlled Citadel Advisors LLC disclosed a 5.3% stake in Western Alliance Bancorp (NYSE: WAL).
Analyst Says Biogen-Eisai’s Alzheimer’s Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Eisai Co Ltd (OTC:ESALY) and Biogen Inc (NASDAQ:BIIB) said the U.S. Department of Veteran Affairs (VA) would provide coverage of their…
Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken
Some Asian firms have disclosed cash deposits at troubled U.S. lender Silicon Valley Bank (NASDAQ: SIVB), known for its deep ties with the healthcare and tech sector. Most emphasized that the amounts were immaterial to their operations.
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
Bristol Myers Squibb & Co’s (NYSE:BMY) Eliquis, Pfizer Inc’s (NYSE:PFE) Ibrance, and AbbVie Inc’s (NYSE:ABBV) Imbruvica are expected to be among the ten…
Provention Bio’s $2.9B Acquisition – A Strategic Fit For Sanofi
Sanofi SA (NASDAQ:SNY) has agreed to acquire Provention Bio Inc (NASDAQ:PRVB) for $25.00 per share in cash, representing an equity value of approximately…